Two More Patents Issued
East Lansing, Michigan (November 14, 2012): Retia Medical, LLC, announced today that two of its patent applications have issued. These patents, US 8,282,569 and US 8,273,031, expand Retia’s broad coverage in the area of cardiovascular signal processing to enable accurate monitoring of critically ill patients using less invasive sensors.
Recent Press Releases:
- Retia Medical Raises $15 Million to Accelerate Commercialization of the Argos Hemodynamic Monitor
- Study Shows that Cardiac Output Measured by the Multi-Beat Analysis (MBA™) Algorithm Correlates with the Pulmonary Artery Catheter in Post-Cardiac Surgery Patients with Arrythmia
- New Study Demonstrates Retia Medical’s Multi-Beat Analysis (MBA™) Algorithm is More Accurate Than a Competing Cardiac Output Monitoring Technology in Cardiac Surgery
- Retia Medical Announces Bernd Saugel has Joined the Clinical Advisory Board